Belgian consensus on metabolic problems associated with atypical antipsychotics.
about
Pharmacological interventions for reducing weight gain in schizophreniaBehavioural interventions for reducing weight gain in schizophreniaAntipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problemsInterventions to reduce weight gain in schizophreniaAntipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problemsMetabolic issues in patients affected by schizophrenia: clinical characteristics and medical managementCare for patients with severe mental illness: the general practitioner's role perspective.Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional studyPhysical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.Interventions for the metabolic syndrome in schizophrenia: a reviewMetabolic monitoring for patients treated with antipsychotic medications.A case series: evaluation of the metabolic safety of aripiprazoleMetabolic Disturbances, Side Effect Profile and Effectiveness of Clozapine in Adolescents.Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness.Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia.Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
P2860
Q24194410-35B2BAF2-1C7F-4F3B-9A05-F3513B94C73CQ24197824-ACD9B910-64A4-42C6-B4A9-040F7E7CC047Q24235450-A7D30F72-2067-4554-B224-2F3E2A98FF2DQ24243093-F269CD8F-8F74-493D-BCA5-17AF688BCFE0Q24244736-BDFAB0EE-F7ED-4B38-BCB3-54E2AB3D98B6Q26783003-7377C38B-BC92-4227-80C2-8D9891F29C4FQ33440011-56F1A8E0-B51A-4CB6-B30E-B201647B0018Q34631699-D42A5FF6-D448-44F3-9D8C-0B552BE8852CQ34944648-53884298-0185-4500-87AC-B629D6D727ADQ35016170-987AB276-7309-4A07-A4F3-2CA29CB6E669Q36401248-5EEE7FB5-9102-4386-B334-FDE5C1B54029Q36577861-46EA5BEB-63CB-412F-BAF1-127BEB43F564Q36853249-25D0E58D-4BFD-4C81-82D3-C3D7AF9A3BF8Q36997233-E71BA83C-4CC2-4C57-B693-EDFD0CF2DE0EQ37865505-94CF1C49-7D79-43D7-A0AF-52683984BC77Q40273385-F9E45AF0-EB4C-4694-93C2-9E1261AAE215Q43099788-EC98A1E3-721A-4932-B5D7-EE7BDE34AAECQ46756223-E173AD65-F9A3-48E3-A9A1-59DB65048409
P2860
Belgian consensus on metabolic problems associated with atypical antipsychotics.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Belgian consensus on metabolic problems associated with atypical antipsychotics.
@en
type
label
Belgian consensus on metabolic problems associated with atypical antipsychotics.
@en
prefLabel
Belgian consensus on metabolic problems associated with atypical antipsychotics.
@en
P2093
P2860
P1476
Belgian consensus on metabolic problems associated with atypical antipsychotics.
@en
P2093
A De Nayer
J Peuskens
L Van Gaal
On Behalf Of The Consensus Group
P2860
P304
P356
10.1080/13651500510018310
P577
2005-01-01T00:00:00Z